Insider · CIK 0001274282

BAUM MARK L

Reports to the SEC for 6 companies · NASHVILLE, TN

sec.gov

Transactions

Companies

Filings

CIK

0001274282

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-14	HROWHARROW, INC.P Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+10K sh	$30.20	+$302K	2,996,130
2025-12-12	HROWHARROW, INC.F Tax Payment	Director, CHIEF EXECUTIVE OFFICER	FTax Payment	−80K sh	$47.06	−$3.76M	2,986,130
2025-12-12	HROWHARROW, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−180K sh	—	—	0
2025-12-12	HROWHARROW, INC.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+180K sh	$3.95	+$711K	3,066,124
2025-07-21	HROWHARROW, INC.F Tax Payment	Director, CHIEF EXECUTIVE OFFICER	FTax Payment	−313K sh	$37.08	−$11.6M	2,886,124
2025-07-21	HROWHARROW, INC.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+600K sh	$7.87	+$4.72M	3,199,462
2025-07-01	HROWHARROW, INC. · RSUA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+890K sh	—	—	889,500
2025-04-07	HROWHARROW, INC.F Tax Payment	Director, CHIEF EXECUTIVE OFFICER	FTax Payment	−300K sh	$23.09	−$6.94M	2,599,462
2025-04-03	HROWHARROW, INC.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+762K sh	—	—	2,899,825
2025-04-03	HROWHARROW, INC. · Performance Stock UnitM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−762K sh	—	—	0
2024-03-22	HROWHARROW, INC.P Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+9,000 sh	$11.59	+$104K	2,137,525
2024-02-20	HROWHARROW, INC. · RSUM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−150K sh	—	—	0
2024-02-20	HROWHARROW, INC.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+150K sh	$10.67	+$1.6M	2,188,361
2024-02-20	HROWHARROW, INC.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−59.8K sh	$10.67	−$638K	2,128,525
2024-02-07	HROWHARROW, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−15.4K sh	—	—	0
2024-02-07	HROWHARROW, INC.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+15.4K sh	$7.71	+$119K	2,038,361
2023-11-16	HROWHARROW, INC.P Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+7,500 sh	$8.11	+$60.8K	2,022,961
2023-08-14	HROWHARROW, INC.P Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+5,800 sh	$17.05	+$98.9K	2,015,461
2023-07-18	HROWHARROW, INC.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+762K sh	—	—	2,309,629
2023-07-18	HROWHARROW, INC. · Performance Stock UnitM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−762K sh	—	—	0
2023-07-18	HROWHARROW, INC.F Tax Payment	Director, CHIEF EXECUTIVE OFFICER	FTax Payment	−300K sh	$18.23	−$5.47M	2,009,661
2023-04-03	HROWHARROW, INC.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+180K sh	$8.99	+$1.62M	1,664,962
2023-04-03	HROWHARROW, INC.F Tax Payment	Director, CHIEF EXECUTIVE OFFICER	FTax Payment	−118K sh	$20.97	−$2.47M	1,547,329
2023-04-03	HROWHARROW, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−180K sh	—	—	0
2023-04-03	HROWHARROW, INC. · Restricted Stock UnitA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+762K sh	—	—	762,300
2023-01-02	HROWHARROW, INC.F Tax Payment	Director, CHIEF EXECUTIVE OFFICER	FTax Payment	−35.2K sh	$14.76	−$519K	1,484,962
2023-01-02	HROWHARROW, INC. · Restricted Stock UnitM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−88K sh	—	—	0
2023-01-02	HROWHARROW, INC.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+88K sh	—	—	1,520,141
2022-12-22	HROWHARROW, INC.P Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+25K sh	$13.39	+$335K	1,432,141
2022-01-20	HROWHARROW, INC.F Tax Payment	Director, CHIEF EXECUTIVE OFFICER	FTax Payment	−71.4K sh	$8.33	−$595K	1,407,141
2022-01-20	HROWHARROW, INC.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+125K sh	$2.40	+$300K	1,478,547
2022-01-20	HROWHARROW, INC. · Stock Option (Right to buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−125K sh	—	—	0
2021-07-23	HROWHARROW, INC. · Restricted Stock UnitA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+762K sh	—	—	762,301
2021-04-25	HROWHARROW, INC. · Restricked Stock UnitM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−850K sh	—	—	0
2021-04-25	HROWHARROW, INC.F Tax Payment	Director, CHIEF EXECUTIVE OFFICER	FTax Payment	−334K sh	$8.26	−$2.76M	1,353,547
2021-04-25	HROWHARROW, INC.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+850K sh	—	—	1,687,676
2021-02-25	HROWHARROW, INC. · Restricted Stock UnitM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−200K sh	—	—	850,000
2021-02-25	HROWHARROW, INC.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+200K sh	—	—	837,676
2021-02-19	HROWHARROW, INC. · Restricted Stock UnitA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+150K sh	—	—	150,000
2020-06-04	HROWHARROW, INC. · Employee Stock Option - Right to BuyD Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−600K sh	—	—	0
2020-06-04	HROWHARROW, INC. · Employee Stock Option - Right to BuyA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+600K sh	—	—	600,000
2020-03-12	ETONEton Pharmaceuticals, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+27.4K sh	—	—	27,400
2020-01-02	HROWHARROW, INC. · Option - Right to BuyA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	−218K sh	—	—	217,500
2020-01-02	HROWHARROW, INC. · Restricted Stock UnitA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	−88K sh	—	—	88,000
2020-01-02	HROWHARROW, INC. · Restricted Stock UnitA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+88K sh	—	—	88,000
2020-01-02	HROWHARROW, INC. · Option - Right to BuyA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+218K sh	—	—	217,500
2019-11-22	HROWHARROW, INC. · Purchase WarrantX Exercise of In-Money	Director, CHIEF EXECUTIVE OFFICER	XExercise of In-Money	−156K sh	—	—	0
2019-11-22	HROWHARROW, INC.X Exercise of In-Money	Director, CHIEF EXECUTIVE OFFICER	XExercise of In-Money	+156K sh	$1.79	+$279K	598,126
2019-02-20	ETONEton Pharmaceuticals, Inc. · Stock option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2019-02-19	HROWHARROW, INC. · Option - Right to BuyA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
May 154
BAUM MARK L0001493152-26-023321
SEC(opens sec.gov)
Dec 164
BAUM MARK L0001493152-25-028036
SEC(opens sec.gov)
Jul 234
BAUM MARK L0001641172-25-020751
SEC(opens sec.gov)
Jul 14
BAUM MARK L0001641172-25-017376
SEC(opens sec.gov)
Apr 74
BAUM MARK L0001641172-25-003109
SEC(opens sec.gov)
Mar 254
BAUM MARK L0001493152-24-011071
SEC(opens sec.gov)
Feb 214
BAUM MARK L0001493152-24-007453
SEC(opens sec.gov)
Feb 84
BAUM MARK L0001493152-24-005371
SEC(opens sec.gov)
Nov 164
BAUM MARK L0001493152-23-041691
SEC(opens sec.gov)
Aug 154
BAUM MARK L0001493152-23-028832
SEC(opens sec.gov)
Jul 204
BAUM MARK L0001493152-23-025150
SEC(opens sec.gov)

Companies

Address

C/O HARROW, INC. 1A BURTON HILLS BLVD., SUITE 200

NASHVILLE, TN, 37215